FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

66 letters match. Newest first.

  1. Lupin Limited

    FDA warned Lupin Limited of current good manufacturing practice (CGMP) violations at its Tarapur API plant involving cleaning and genotoxic impurity controls.

    High risk
  2. System Kosmetik Produktionsgesellschaft fur kosmetische Gmbh

    German OTC drug maker System Kosmetik was cited for manufacturing quality violations, including missing process and cleaning validation.

    High risk
  3. Zhejiang Tianyu Pharmaceutical Co., Ltd.

    Zhejiang Tianyu Pharmaceutical made active pharmaceutical ingredients (API) with current good manufacturing practice (CGMP) deviations in impurity investigations and equipment cleaning.

    High risk
  4. Jost Chemical Co.

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  5. Bioiberica, SAU

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  6. Fagron Group B.V.

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  7. Specialty Process Labs LLC

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  8. Miami University Department of Chemistry and Biochemistry

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  9. Indiana Chem-Port

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  10. Aurobindo Pharmaceutical Limited

    FDA warned Aurobindo Pharmaceutical Limited after an inspection found manufacturing practice failures in drug ingredients and inadequate investigations.

    High risk
  11. Adamson Analytical Laboratories, Inc.

    FDA warned California contract drug-testing lab Adamson over inadequate computer controls and data integrity failures.

    High risk
  12. Marcus Research Laboratory, Inc.

    FDA warned Marcus Research Laboratory after a May 2021 inspection found it released povidone iodine API made after reactor fires and smoke without fully testing for contamination.

    High risk
  13. Missouri Analytical Laboratories Inc

    Missouri Analytical Laboratories, a contract drug testing lab, cited for manufacturing practice violations including inadequate out-of-specification investigations and data integrity failures.

    High risk
  14. Syntec Pharma Corp

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  15. Proquimes S A Productos Quimicos Especializados S.A.

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  16. Professional Compounding Centers of America dba PCCA

    PCCA received adulterated drug ingredients from suppliers on FDA import alerts and failed adequate glycerin identity testing.

    High risk